Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals’ Hepatitis B Vaccine (HBV), Engerix-B
Condition(s):Hepatitis B VaccineLast Updated:January 2, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Hepatitis B VaccineLast Updated:January 2, 2020Completed
Condition(s):Hepatitis BLast Updated:January 18, 2020Completed
Condition(s):Hepatitis BLast Updated:March 20, 2019Completed
Condition(s):Hepatitis BLast Updated:August 20, 2018Completed
Condition(s):Hepatitis BLast Updated:August 20, 2018Completed
Condition(s):Hepatitis B VaccinesLast Updated:July 17, 2020Completed
Condition(s):Hepatitis BLast Updated:July 31, 2018Completed
Condition(s):HIV; Communicable Diseases; Hepatitis B; HBV; Infectious DiseasesLast Updated:September 29, 2022Completed
Condition(s):Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; PoliomyelitisLast Updated:December 17, 2013Completed
Condition(s):Chronic Kidney DiseaseLast Updated:March 20, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.